Share
   
Title
Code
Session Type
Venue
Date Time
Co-Chairs:
16:30
WEAA0201
Investigating the SHIV reservoir in a non-human primate model following allogeneic bone marrow transplantation
Lucrezia Colonna, University of Washington, United States
Abstract
16:45
WEAA0202
Investigating clinical therapeutics to target infected cells and promote HIV clearance
Philip Arandjelovic, The Walter and Eliza Hall Institute of Medical Research, Australia
Abstract
Slides
17:00
WEAA0203
Inhibiting memory CD4+ T-cell self-renewal to reduce HIV persistence
Maud Mavigner, Emory University, United States
Abstract
Slides
17:15
WEAA0204
PBMCs from patients with chronic myeloid leukemia treated with different tyrosine kinase inhibitors show variable susceptibility to HIV-1 infection: searching for the best therapeutic approach
Mayte Coiras, Instituto de Salud Carlos III, Spain
Abstract
Slides
17:30
WEAA0205
Eradication without reactivation: suppression of HIV-1 transcription and reactivation from latency by a Tat inhibitor
Susana Valente, The Scripps Research institute, United States
Abstract
17:45
WEAA0206
Myeloablative conditioning is dispensable for transplant-dependent HIV cure
Hans-Peter Kiem, Fred Hutchinson Cancer Research Center, United States
Abstract